Page contentsPage contents Key facts Decision Key facts Active substance Dronabinol Therapeutic area Pain Decision number P/214/2010 PIP number Dronabinol Pharmaceutical form(s) Oral solution Condition(s) / indication(s) Treatment of central and peripheral neuropathic pain Route(s) of administration Oral use Contact for public enquiries Bionorica AG info@bionorica.deGermanyPhone: +49 918132190Fax: +49 9181231265 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 29/10/2010 Compliance check done No Decision P/214/2010: European Medicines Agency decision of 29 October 2010 on the granting of a product specific waiver for dronabinol (EMEA-000643-PIP01-09)Adopted Reference Number: EMA/655072/2010 English (EN) (71.18 KB - PDF)First published: 25/11/2010 Last updated: 25/11/2010 View Share this page